Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

09Jul

Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

Portfolio News
Corbus Pharmaceuticals, a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors. Read more >>

Share this post

Related Posts

24Nov

The search for a pill that treats concussions

William Korinek loves professional football and, as a native Minnesotan who moved to New England in 1995, he roots for... read more
10Aug

Local company making strides toward longer-lasting EpiPen alternative

It's that time of year again when some parents go on the hunt for an elusive pharmaceutical product. Once again,... read more
23Jun

Savvy Shopper: How to save money when buying toys

Let’s face it, toys are expensive. But they help to stimulate, educate, and occupy our busy kids when we need... read more
04Aug

Wasabi Technologies appoints Australian country manager

US-based cloud storage vendor Wasabi Technologies has appointed Andrew Sandes as country manager for Australia. n the new role for... read more
24Jun

eSight prepares to release next generation of its technology

“The ability of the technology to really have a dramatic impact of an individual’s life,” is one of the most... read more
02Oct

Corbion, KnipBio score wins for their alternative aquafeeds

Corbion and KnipBio each secured positive developments recently in the advancement of the development and marketing of their alternative aquafeed... read more
30Sep

The Next COVID Challenge: Building an Arsenal of Vaccines

For months, international partners have pressured the United States about intellectual property (IP) concerns and access to SARS-CoV-2 vaccines. As... read more
06Apr

Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries

Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, is pleased... read more
29Jun

The Pace Of Children’s Retail Innovation Speeds Up

Hope springs eternal. That sense of hope is a big part of childhood, and it applies as well to retail... read more
08Sep

Akston starts small and likes it that way

Akston Biosciences Corp. emerged from a successful small company that was sold to a pharma major. For Todd Zion, that’s... read more